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Present study introduces results of common influenza virus strains in the north 
of Iran. Samples collected from 65 patients with acute respiratory illness by throat 
washing and swabs, randomly from north of Iran (Mazandaran, Golestan and 
Guilan provinces). The patients suffered from fever (high), cough, sore throat, 
general malaise, chill and myalgia. Viruses were isolated by cell culture and 
confirmed with HA (Hemagglutimtion) test and then typed by and HI 
(Hemagglutination Inhibition) test. Out of 65 throat samples, 12 influenza viruses 
were isolated and typed. Isolated viruses belonged to A (HlNl), A (H3N2) and 
B influenza viruses. This study showed that Influenza viruses displayed identical 
pattern to other provinces in Iran and to other countries. To fight against 
epidemics and pandemics, we should collect enough data about status of 
influenza each year and data of exact vaccine formulation application for use in 
different areas of the world. Acquired data has shown that the vaccine for above 
viruses that confirmed by "WHO can result in decreased risks of influenza in at risk 
cases in provinces of north Iran. 
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INTRODUCTION 
Influenza virus infection is a broad spectrum clinical 
response from an asymptomatic infection to fatal viral 
pneumonia. Influenza viruses are transmitted person-to­
person through respiratory secretions (David et al., 2001). 
High percent of the world population is infected with the 
virus annually. In Iran large populations acquire the 
infection in the epidemic months and most of them 
present with systemic and local clinical features like: high 
grade fever, chills, dry cough, headache, agitation and 
generalized muscular pain (White and Fenner, 1994; 
Maurice, 2002). 
Influenza is noted as an important, acute and common 
infection of the respiratory tract. Causal influenza viruses 
have 3 types: A, Band C (David et al., 2001, White and 
Fenner, 1994). Type A, the most important type, causes 
annual epidemics in the cold seasons. Type B and C are 
less important (Maurice, 2002). 
Type A can cause epidemics and pandemics in the 
world, that is the result of antigenic drift and antigenic 
shifts of the surface antigens (H = Hemagglutinin and 
N ~ Neuramimdase) (David et al., 2001; Peter et al., 2001). 
Influenza epidemics occur in the cold months, naturally. 
It causes at list 3000-4000 deaths in England in annually 
and death rate is higher in the old ages (Health 
Organaization, 2005). 
As a network of national laboratories is created by 
WHO to monitor Influenza and isolate the common strains 
and it presents new vaccines due to the reports of such 
laboratories; so it is wise to evaluate the common viruses 
in all local provinces. Iran national Influenza center is 
located in the Institute of Hygienic Researches in Tehran 
University of Medical Sciences that isolates and types the 
viruses to identify new strains. 
Present study introduces results of common influenza 
virus strains in the north of Iran (Mazanderan, Golestan 
and Guilan) in, 2005. 
MATERIALS AND METHODS 
Sampling: Samples of pharyngeal washing and throat 
swab were taken from 65 suspected patients with 
symptoms of acute respiratory infection in December, 
January and February (2005-2006). 
Samples were taken randomly from clinics and primary 
schools. All cases had fever (high), chill, cough, sore 
throat, agitation and muscular pain. All age groups were 
included. Sampling continued to the first influenza viruses 
A and B and no special sample size is noted. They were 
transported to the national influenza laboratory at 
Division of Virology, Department of Pathobiology, School 
of Public Health and Institute of Public Health Research, 
Tehran University of Medical Sciences within 5 days, in 
cold string ( 4°C) in transport buffer (PBS with penicillin, 
streptomycin and amphotricin Band 0.5% glycerol). 
Virus isolation: Samples were inoculated with 1.1DCK 
(Madin Darby Canine Kidney) and monitored as the 
cellular changes in a week. If a live virus presents 
cenotaphic effects could be seen in 2-3 days but cellular 
cultures were evaluated to one week for more accuracy. 
Method culture had showed this the best growth in RPM! 
(Roswell Park Memorial Institute, Gibco, UK). Serum free 
cultures with 2 mg mL-i TPCK were used in the 
inoculation time for easy isolation and kept in 33-34°C. 
Confirmation of virus presentation with HA: In samples 
with CPE due to virus growth, hemagglutination with 
chicken or hamster RBCs was done after getting the 
surface product. 
Globules were agglutinated if virus was present. 
Negative samples or lower titers were inoculated to 
the cellular cultures again and HA was done on the 
final products. 
Typing of the isolated viruses with ID: Samples with 
antigenic titer of 4 or higher mrits of hemagglutinin, were 
typed and samples with titers less than 4 units were added 
to the cells to increase the titer. 
Typing was done with the reference anti-sera 
[ AIH3N2/Fujian/411/2002-like, A/HI NI ;New Caledonia/ 
20/99-like, AIH3N2/Moscow/l 0/99-like, B!Hong 
Kong/330/2001-like, B/Sichuan/379/99-like (WHO 
Collaborating Centre for Reference and Research on 
Influenza, Melbourne, Australia)] and hemagglutination 
inhibition method. Chicken or hamsters RBCs were used. 
RESULTS 
Thirty eight samples from female (58.5%) and 27 from 
male (41.5%) were taken as shown in Table 1. The 
yollllgest was a 2-years-old boy and the oldest was a 
75-years-old male. The mean age was 33 years. Twelve 
influenza viruses were isolated and typed from 65 
suspected cases. Both influenza virus type A and B were 
present in north of Iran. 
Table 1: Types of common Influenza viruses in North of Iran (2005-2006) 
Cases T e ofvims 
2 A/New/Caledonia/20/99-like(HlNl) 
4 A/Moscow/10/99-like (H3N2) 
3 B/Sichuan/379/99-like 
3 B/Hong Kong/330-2001-like 
12 Total 
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DISCUSSION 
A natural epidemic of influenza contaminates 5-15% 
of the population (Bridges et al., 2000). It can cause 
serious disease and high rate of death in children and old 
ages (80-90% of deaths in the epidemics belong to the 
persons more than 65-years-old), immllllocompromised 
patients or chronic heart diseases, diabetes mellitus, 
chronic gastrointestinal diseases with difficult defecation, 
cancer patients, alcoholics and asthmatic patients 
(Nobert et al., 2002; Gurfinkel et al., 2002; Anonymous, 
2003). 
The Centers for Disease Control and Prevention's 
Advisory Committee on Immllllization Practices (ACIP) 
and the American Academy of family physicians now 
recommend that all adults above age 50 be routinely 
offered the vaccine, in addition to yollllger people with 
chronic medical conditions including those with heart 
disease (Peter et al., 2001). 
ACIP have proposed that the age of vaccination 
should be decreased from 65 years to 50-years-old, 
because 24-32% of persons over 50-years-old suffer from 
chronic diseases, their hospitalization due to influenza 
infection is long lasting and sometimes results to death 
(Bridges et al., 2000). 
Some practices have been done in countries like 
America, European country, in Asia prepared valuable 
practical programs to be used in other that countries 
initiating the program. Coming pandemics are expected, 
despite these progressions (Nancy et al., 2003). 
Accurate monitoring of the virus changes is the best 
method to fight it. Virus antigenic changes should be 
noted annually with isolation and typing of the suitable 
vaccines and medicines should be prepared (David et al., 
2001 ). 
As shown in the Table 1, in 2005-2006 in the north of 
Iran, influenza virus type A (HlNl) was circulated in a low 
level, like the other parts of the world and it was similar to 
A/new caledonia/20/99 virus. 
Influenza virus type A (H3N2) isolated in this study 
was similar to A!Moscow/l 0/99 virus. Presentation of this 
subtype is not reported from the other sites of the 
COlllltry. 
Influenza virus type B was more prevalent in the area. 
In the other sites of the colllltry, influenza virus type B 
were seen in eastern Azarbaijan, Hamedan, Y azd, 
Hormozgan, Boushehr, Isfahan and Khorasan. But in 
other colllltries, except for Japan, it has a lower level 
(Weekly Epidemiological Record, 2005). No prevalence of 
this type was reported in September 2005 and January 
2006 (Weekly Epidemiological Record, 2006). 
Influenza virus type A (H3N2, HlNl) is reported in 
other provinces (unpublished data). In 1997 influenza 
virus type A and B were isolated in national influenza 
center (Mokhtari-Azad et al., 1999). 
Seroepidemiologic studies in Iran showed Influenza 
virus type A (H3N2) in 1991-92,1997-98and1999-2000, 
then virus type A (HlNl) and type B were reported in 
2000-2001 (Mokhtari-Azad et al., 2004). 
Four epidemics of influenza virus type A (H3N2, 
HlNl) are reported from 50 colllltries that reported their 
influenza activities in September 2005 to January 2006. A 
(H3N2) is reported in Camda, Japan and the Uinted 
States. A (HlNl) is reported in Tunes. But Type Bis not 
reported (Weekly Epidemiological Record, 2006). 
Wet and moderate weather in the north of Iran may 
plays a role in the incidence and severity of clinical 
presentation of influenza. A relationship between 
influenza and temperature has been suggested before 
(K yriazopolou et al., 1995). 
We should have enough data about the influenza 
states in the region with examination on the samples 
especially in high risk persons to prepare suitable 
protocols for the commmrity. 
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